<div id="readability-page-1"><div> <div> , /PRNewswire/ -- According to MarketsandMarkets™, the Veterinary Vaccines Market is projected to grow from about USD 13.02 billion in 2026 to USD 18.46 billion by 2031, at a CAGR of 7.2%. Browse 302 market data Tables and 60 Figures spread through 450 Pages and in-depth TOC on &#34;Veterinary Vaccines Market- Global Forecast to 2031&#34; Veterinary Vaccines Market Size &amp; Forecast: <ul type="disc"> <li>Market Size Available for Years: 2025–2031</li> <li>2026 Market Size: USD 13.02 billion</li> <li>2031 Projected Market Size: USD 18.46 billion</li> <li>CAGR (2026–2031): 7.2%</li> </ul> Veterinary Vaccines Market Trends &amp; Insights: <ul type="disc"> <li>Based on type, the livestock vaccines segment accounted for the largest share of 28.6%.</li> <li>By disease, the livestock vaccines segment accounted for the largest share of 31.4% in 2025.</li> <li>Asia Pacific is the fastest-growing market for veterinary vaccines during the forecast period.</li> </ul> Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233 The veterinary vaccines market is experiencing significant growth, which can primarily be attributed to the growth in the companion animal population, growing pet ownership, rising incidence of zoonotic diseases, and initiatives by government agencies to improve animal health. On the other hand, the high cost associated with vaccines is expected to restrain the growth of this market to a certain extent. Navigating these drivers and restraints will be crucial for the future development and adoption of veterinary vaccine solutions. By type, the companion animal vaccines segment is expected to register the highest growth rate in the global veterinary vaccines market. The companion animal vaccines market is growing significantly, driven by increasing pet ownership, heightened awareness of preventive healthcare, and the development of more effective and safer vaccines. As pets are increasingly viewed as family members, the demand for vaccinations to protect them from infectious diseases is rising. The growing recognition of zoonotic disease risks, government regulations, and the rise of pet insurance are further boosting vaccine demand. Additionally, emerging markets, particularly in Asia Pacific, are contributing to this growth as disposable incomes rise and more pet owners seek veterinary care. Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1233 By application, the veterinary hospitals segment is anticipated to grow at a significant rate in the veterinary vaccines market during the forecast period. The veterinary hospitals segment is growing quickly as more pet owners seek professional care for their pets. With pets being treated like family, owners turn to veterinary hospitals for vaccinations and overall health care. These hospitals offer advanced vaccines and follow-up care, making them a go-to choose for ensuring pets stay healthy. Partnerships with pharmaceutical companies and the growing focus on preventive care are also helping drive this growth. As a result, veterinary hospitals are becoming an increasingly important part of the pet healthcare landscape. The Asia Pacific market is expected to register the highest growth rate during the forecast period. The veterinary vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East &amp; Africa. The Asia Pacific region is experiencing rapid growth in the veterinary vaccines market, driven by rising pet ownership, increasing awareness of pet health, and growing disposable incomes. As more people in countries like China, India, and Southeast Asia adopt pets, there is a rising demand for veterinary care, including vaccinations. The expansion of veterinary hospitals, along with government initiatives to improve animal health and prevent zoonotic diseases, is further boosting vaccine adoption. This combination of factors makes Asia Pacific one of the fastest-growing regions in the veterinary vaccines market. Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1233 Top Companies in Veterinary Vaccines Market: The Top Companies in Veterinary Vaccines Market include Zoetis (US), Merck &amp; Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco (US), Virbac (France), Ceva (France), Phibro Animal Health Corporation (US), Hester Biosciences Limited (India), Neogen Corporation (US), HIPRA (Spain), and Biogénesis Bagó (Argentina), among others. Browse Adjacent Markets: Pharmaceuticals Market Research Reports &amp; Consulting Related Reports: Vaccine Adjuvants Market - Global Forecast to 2029 Veterinary Diagnostics Market - Global Forecast to 2030 Veterinary Imaging Market - Global Forecast to 2029 Allergy Diagnostics Market - Global Forecast to 2029 Veterinary Reference Laboratory Market - Global Forecast to 2030 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: +1-888-600-6441 Email: [email protected] Visit Our Website: https://www.marketsandmarkets.com/ Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg SOURCE MarketsandMarkets <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE5Jk5ld3NJdGVtSWQ9SU82NTgyMiZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTkxMDMwUFJfTkVXU19VU1BSX19fX19JTzY1ODIy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE5Jk5ld3NJdGVtSWQ9SU82NTgyMiZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTkxMDMwUFJfTkVXU19VU1BSX19fX19JTzY1ODIy"/></div> </div></div>

The Veterinary Vaccines Market is projected to grow from USD 13.02 billion in 2026 to USD 18.46 billion by 2031, at a CAGR of 7.2%. The growth is driven by increasing pet ownership, rising zoonotic diseases, and government initiatives for animal health. The Asia Pacific region is expected to see the highest growth due to rising disposable incomes and pet care awareness. The companion animal vaccines segment is anticipated to grow significantly, with veterinary hospitals becoming key players in pet healthcare. Major companies in this market include Zoetis, Merck, and Boehringer Ingelheim.

10:30 ET Veterinary Vaccines Market worth $18.46 billion by 2031 | MarketsandMarkets™